When we talk about neuroprotection, we mean the upkeep and preservation of neuronal structure and function as well as the avoidance of neuronal harm and death. Treatment for a number of brain conditions, including multiple sclerosis, Alzheimer’s disease, and Parkinson’s disease, among others, requires neuroprotection. The rising prevalence of neurological disorders and the rising demand for efficient treatments are anticipated to fuel the growth of the global neuroprotection market over the coming years.
Neuroprotection is a pharmacological or chemical strategy that prevents the onset of neurodegenerative diseases while preserving neural function. It can be applied to stop various injuries or insults from harming the brain, spinal cord, and peripheral nerves. Additionally, neuroprotective drugs can help patients with pre-existing brain conditions manage their symptoms. The process of protecting neurons from damage of any kind is referred to as neuroprotection. It can be primary or secondary depending on whether the harm was intentionally created (primary) or if it resulted from another treatment (secondary). Neuroprotective therapies seek to prevent further damage and promote healing.
The market is divided into Free Anti-Inflammatory Agents, Radical Trapping Agents (Antioxidants), Apoptosis Inhibitors, Glutamate Antagonists (Anti-Excitotoxic Agents), Neurotrophic Factors (NTFs), Stimulants, Metal Ion Chelators, and Others based on type.
Market Size and Growth
According to the recent report, the global neuroprotection market is expected to grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2032. The market was valued at USD 6.89 billion in 2020 and is projected to reach USD 11.62 billion by 2028.
The growth of the neuroprotection market is driven by several factors, including the increasing prevalence of neurological disorders, the growing demand for effective treatments, and the development of novel neuroprotective drugs and therapies. Additionally, the aging population and the rising incidence of traumatic brain injuries are expected to drive market growth in the coming years.
Since many of the underlying mechanisms of damage to neural tissues are the same in all of these conditions and several products are used in more than one disorder, this report discusses the role of neuroprotection in acute disorders like stroke and injuries to the nervous system as well as in chronic diseases like neurodegenerative disorders.
The phases that neuroprotective treatments aim to treat are described alongside the disease mechanisms. Among the diseases covered are ischemic optic neuropathy, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, spinal cord injuries, and ischemic optic neuropathy. Although anaesthetics like propofol are also neuroprotective, the purpose of talking about neuroprotection during surgery and anaesthesia is to prevent and control complications that result in CNS damage.
This report examines all the key factors influencing growth of global Neuroprotection market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Neuroprotection market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.
Market Segmentations:
Global Neuroprotection Market: Major Players
Nyrada – Biotechnology Company
Eli Lilly and Company
FierceBiotech
Zocere, Inc.
IntraBio
Paladin Labs Inc
Astrocyte Pharmaceuticals Inc.
Novartis
Allon Therapeutics Inc.
Global Neuroprotection Market: Types
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others
Global Neuroprotection Market: Applications
Prevention
Treatment
Global Neuroprotection Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Neuroprotection market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.
Analysis of the impact of COVID-19 and the Russia-Ukraine War:
The readers of this section will be better informed on the effects of the pandemic, the post-pandemic, and the Russia-Ukraine War on the global market for refrigerated freight services. The factors that have changed since the poll was done include demand, consumption, transportation, consumer behavior, and supply chain management. Industry experts have also emphasized the crucial factors that will help players identify opportunities and maintain the sector as a whole in the approaching years.
Conclusion
In conclusion, the global neuroprotection market is expected to grow in the coming years, driven by the increasing prevalence of neurological disorders and the growing demand for effective treatments. The development of novel neuroprotective drugs and therapies, as well as the aging population and the rising incidence of traumatic brain injuries, are expected to drive market growth. The key players in the market are engaged in the development of innovative therapies, as well as strategic collaborations and partnerships to expand their product offerings and strengthen their market position.
Reasons to Purchase the Neuroprotection Market Report:
- The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
- Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
- Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
- The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
- Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
More Trending Reports:
Sickle Cell Anemia Therapeutics Market: https://analyticsmarketresearch.com/reports/sickle-cell-anemia-therapeutics-market/1727/
Back & Shoulder Braces Market: https://analyticsmarketresearch.com/reports/back-&-shoulder-braces-market/1669/
Drug Eluting Stents (DES) Market: https://analyticsmarketresearch.com/reports/drug-eluting-stents-(des)-market/1629/
